Teva (TEVA) director receives 7,242 RSUs vesting in May 2027

Rhea-AI Filing Summary

Satchi-Fainaro Ronit reported acquisition or exercise transactions in this Form 4 filing.

TEVA PHARMACEUTICAL INDUSTRIES LTD director RSU grant: Director Ronit Satchi-Fainaro received 7,242 restricted share units as a compensation award. Each unit represents a contingent right to receive one ordinary share or, at the committee’s option, the cash value of one share. The award was granted on May 28, 2026 and will vest on May 28, 2027, subject to the plan’s conditions. Following this grant, the director holds 7,242 RSUs directly, and these may be settled in ordinary shares, which can be represented by American Depositary Shares on a 1:1 basis.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Satchi-Fainaro Ronit

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	7,242	$0.00	--

Holdings After Transaction: Restricted Share Units — 7,242 shares (Direct, null)

Footnotes (1)

1. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on May 28, 2026 and vest on May 28, 2027. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Key Figures

RSUs granted: 7,242 units RSUs vesting date: May 28, 2027 Shares per RSU: 1 ordinary share per RSU +3 more

6 metrics

RSUs granted 7,242 units Restricted share units granted on May 28, 2026

RSUs vesting date May 28, 2027 Vesting date for 7,242 RSUs

Shares per RSU 1 ordinary share per RSU Each RSU represents a contingent right to one ordinary share

ADS ratio 1 ADS = 1 ordinary share Ordinary Shares may be represented by ADS on a 1:1 basis

Holdings after grant 7,242 RSUs Total restricted share units directly held after transaction

Grant price $0.0000 per unit Compensation grant with no exercise or purchase price

Key Terms

Restricted Share Units, contingent right, vest, American Depositary Shares

4 terms

Restricted Share Units financial

"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

contingent right financial

"represents a contingent right to receive, at settlement, one ordinary share or the cash value"

vest financial

"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

American Depositary Shares financial

"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Satchi-Fainaro Ronit

(Last) (First) (Middle)

C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.

124 DVORA HANEVI'A ST.,

(Street)

TEL AVIV ISRAEL 6944020

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
TEVA PHARMACEUTICAL INDUSTRIES LTD [ TEVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	05/28/2026		A		7,242		(2)	(2)	Ordinary Shares(3)	7,242	$0	7,242	D

Explanation of Responses:

1. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

2. Restricted share units were granted on May 28, 2026 and vest on May 28, 2027.

3. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

	/s/ Dov Bergwerk as attorney-in-fact for Ronit Satchi-Fainaro	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did TEVA director Ronit Satchi-Fainaro report?

Ronit Satchi-Fainaro reported receiving a grant of 7,242 restricted share units. These RSUs are a form of equity compensation and do not involve an open-market stock purchase or sale, but give a future right to ordinary shares or their cash value.

How many TEVA restricted share units were granted and what do they represent?

The director received 7,242 restricted share units. Each RSU represents a contingent right to receive one TEVA ordinary share, or the cash value of one share, upon settlement, giving the director potential future ownership rather than immediate tradable shares.

When do the 7,242 TEVA restricted share units granted on May 28, 2026 vest?

The 7,242 restricted share units vest on May 28, 2027. Vesting means the director must remain eligible under the plan’s terms until that date before RSUs convert into ordinary shares or an equivalent cash payment, if the committee chooses cash settlement.

Are TEVA’s restricted share units granted to the director settled in shares or cash?

Each restricted share unit can be settled in one ordinary share or the cash value of one share. The Human Resources and Compensation Committee decides the settlement form at vesting, giving flexibility between delivering equity or cash based on plan decisions.

How are TEVA ordinary shares from RSUs related to American Depositary Shares (ADS)?

TEVA states its ordinary shares may be represented by American Depositary Shares. Each ADS currently represents one ordinary share, so RSUs that settle into ordinary shares could correspond to the same number of ADS, depending on how the holder chooses to own them.

Did the TEVA director buy or sell shares on the market in this Form 4?

The filing reflects a grant of 7,242 restricted share units, not an open-market trade. It is coded as a compensation-related acquisition and shows no market purchase or sale, only the award of RSUs that may later convert into shares or cash.